MedDataX Logo

Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication

NCT00946868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2009-07-27

No results posted yet for this study

Summary

Metabolic syndrome, a group of cardiovascular risk factors related to insulin resistance, is a major determinant of cardiovascular mortality.

Intermittent claudication is a symptom of an early stage of atherosclerosis.

The aim of this study is to determine the prevalence of the metabolic syndrome in patients with intermittent claudication and its correlation with age, gender, localization of arterial obstruction and association with coronary artery disease.

Conditions

  • Intermittent Claudication
  • Metabolic Syndrome X

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Nelson Wolosker, PhD · University of Sao Paulo

  • Pedro P Leao, PhD · University of Sao Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Brazil

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946868 on ClinicalTrials.gov